Zoetis Inc. Operating Lease, Liability, Noncurrent
Zoetis Inc. (ZTS) had Operating Lease, Liability, Noncurrent of $190.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $190.00M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $193.00M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $197.00M; Operating Lease, Liability, Noncurrent as first filed $196.00M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $204.00M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $190.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $193.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $197.00M 10-Q · filed 2026-08-06 | $196.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $204.00M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $210.00M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $173.00M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $174.00M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $181.00M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $181.00M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $184.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $188.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $191.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $188.00M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $180.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $186.00M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $186.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $161.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $158.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $151.00M 10-K · filed 2023-02-14 | |
| 2021-09-30 | $160.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $147.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $159.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $163.00M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $167.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $155.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $159.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $164.00M 10-K · filed 2021-02-16 | |
| 2019-09-30 | $169.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $169.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $134.00M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-13 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |